SYNLAB AG provided earnings guidance for the year 2023. The Group continues to expect revenues of around EUR 2.7 billion in Fiscal Year 2023 considering the sale of the operations in Switzerland, the operations in Poland and Ukraine as well as the veterinary diagnostics business in Belgium, Germany, and Spain with an overall anticipated contribution to revenue generation of around EUR 38 million in Fourth Quarter 2023.
Market Closed -
Other stock markets
|
After market 03:58:00 pm | |||
10.3 EUR | +0.19% | 10.32 | +0.19% |
May. 08 | Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Laboratory chain Synlab starts the year with lower revenue | DP |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.81% | 2.44B | |
-13.90% | 8.58B | |
+63.16% | 4.12B | |
-3.34% | 2.48B | |
-43.01% | 2.29B | |
-4.82% | 2B | |
-18.74% | 1.53B | |
-40.24% | 1.21B | |
+9.42% | 1.12B | |
+12.53% | 940M |
- Stock Market
- Equities
- SYAB Stock
- News SYNLAB AG
- SYNLAB AG Provides Earnings Guidance for the Year 2023